Here’s Why Diamond Hill Mid Cap Composite Purchased Revvity (RVTY) in Q3

Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Markets continued their rally in the third quarter, with US stocks gaining over 8% as measured by the Russell 3000 Index. Small-cap stocks experienced the strongest quarterly performance, rising by more than 12%, whereas large-cap stocks increased by about 8%, and mid-cap stocks saw a gain of 5%. The strategy underperformed the Russell Midcap Index in the third quarter, returning 4.49% net vs. 5.33% for the Index. For more information on the fund’s top picks in 2025, please check its top five holdings.

In its third-quarter 2025 investor letter, Diamond Hill Mid Cap Strategy highlighted stocks such as Revvity, Inc. (NYSE:RVTY). Revvity, Inc. (NYSE:RVTY) is a health sciences solutions, technologies, and services company. The one-month return for Revvity, Inc. (NYSE:RVTY) was -5.16%, and its shares lost 12.70% over the last 52 weeks. On December 30, 2025, Revvity, Inc. (NYSE:RVTY) stock closed at $97.43 per share, with a market capitalization of $11.309 billion.

Diamond Hill Mid Cap Strategy stated the following regarding Revvity, Inc. (NYSE:RVTY) in its third quarter 2025 investor letter:

“Though markets have continued rising throughout the year, we have continued finding individual companies whose prices we believe are not reflective of their long-term growth outlooks. Accordingly, we initiated several new positions in Q3, including Toro Company, Equitable Holdings, Cooper Companies and Revvity, Inc. (NYSE:RVTY).

Revvity is a life sciences tools and diagnostics company that provides instruments and consumables for preclinical drug research. The company has upgraded its product portfolio to offerings which generate higher margins, and so we took advantage of investors’ concerns about biopharmaceuticals policy uncertainty to add a position at a discount to our estimate of intrinsic value.”

In another article, we covered Revvity, Inc. (NYSE:RVTY) and shared the list of stocks Jim Cramer discussed. In addition, please check out our hedge fund investor letters Q3 2025 page for more investor letters from hedge funds and other leading investors.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. This article is originally published at Insider Monkey.